Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Versus Propofol for Rapid Sequence Intubation in Critically Ill Patients
NCT07847255Phase 4Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine in critical illness (2 arms). Primary endpoint: Lowest Mean Arterial Pressure at 10 minutes. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT07847255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07847255.